YORK — The acquisition of IGM Resins, a provider of intermediates to the
global ultraviolet ("UV") radiation cure coatings, inks and adhesives
industry, was announced by Arsenal Capital Partners, a leading New York-based
private equity firm that invests in middle-market specialty industrial and
healthcare companies. UV technologies
are used in numerous end markets, including printing, packaging, electronics
in 1999, and headquartered in the Netherlands, IGM Resins is a global specialty
chemical company and leading supplier of photoinitiators and acrylates to the
worldwide UV curable coatings and inks markets.
In 2010, the company acquired the Photomer brand UV Acrylates business
from Cognis, providing it with a fully integrated product portfolio, including
UV curable monomers, epoxy Acrylates, polyester and polyether Acrylates and
Resins'' strategy is to expand its product portfolio, services, production,
technical support and product development in support of the high growth UV
radiation cure market.
acquisition of IGM is the fourth acquisition by Arsenal Capital in 2012,
following investments in Fluoro-Seal Holdings, Plasticolors Inc. and Evonik''s
Colorants business. IGM joins Arsenal''s extensive portfolio of investments in
the specialty industrials sector.
currently has $1.1 billion of committed equity capital.